Socorro Asset Management LP Eli Lilly & CO Transaction History

Socorro Asset Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3.23 Million - $3.79 Million	-11,576 Reduced 35.08%	21,427 $6.95 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.14 Million - $1.41 Million	-4,850 Reduced 12.81%	33,003 $9.45 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $2.05 Million - $2.55 Million	-9,126 Reduced 19.43%	37,853 $10.5 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $1.87 Million - $2.3 Million	8,445 Added 21.92%	46,979 $10.9 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $427,722 - $553,256	2,369 Added 6.55%	38,534 $8.84 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $58,497 - $75,728	-356 Reduced 0.97%	36,165 $6.76 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $4.76 Million - $6.3 Million	36,521 New	36,521 $6.17 Million

4,031

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Socorro Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Socorro Asset Management LP with notifications on news.